These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 21300897)

  • 1. Metabolic cross-talk allows labeling of O-linked beta-N-acetylglucosamine-modified proteins via the N-acetylgalactosamine salvage pathway.
    Boyce M; Carrico IS; Ganguli AS; Yu SH; Hangauer MJ; Hubbard SC; Kohler JJ; Bertozzi CR
    Proc Natl Acad Sci U S A; 2011 Feb; 108(8):3141-6. PubMed ID: 21300897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the performance of secretome analysis based on metabolic labeling by three unnatural sugars].
    Mao Y; Zheng J; Feng S; Tian R
    Se Pu; 2021 Oct; 39(10):1086-1093. PubMed ID: 34505430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Precise identification of
    Guo Z; Li H; Qin W
    Se Pu; 2021 Nov; 39(11):1182-1190. PubMed ID: 34677013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation.
    Nagel AK; Schilling M; Comte-Walters S; Berkaw MN; Ball LE
    Mol Cell Proteomics; 2013 Apr; 12(4):945-55. PubMed ID: 23443134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced transfer of a photocross-linking N-acetylglucosamine (GlcNAc) analog by an O-GlcNAc transferase mutant with converted substrate specificity.
    Rodriguez AC; Yu SH; Li B; Zegzouti H; Kohler JJ
    J Biol Chem; 2015 Sep; 290(37):22638-48. PubMed ID: 26240142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for the Detection, Study, and Dynamic Profiling of O-GlcNAc Glycosylation.
    Thompson JW; Griffin ME; Hsieh-Wilson LC
    Methods Enzymol; 2018; 598():101-135. PubMed ID: 29306432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of Cu (I)-catalyzed alkyne-azide cycloaddition (CuAAC) and strain-promoted alkyne-azide cycloaddition (SPAAC) in O-GlcNAc proteomics.
    Li S; Zhu H; Wang J; Wang X; Li X; Ma C; Wen L; Yu B; Wang Y; Li J; Wang PG
    Electrophoresis; 2016 Jun; 37(11):1431-6. PubMed ID: 26853435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A chemical approach for identifying O-GlcNAc-modified proteins in cells.
    Vocadlo DJ; Hang HC; Kim EJ; Hanover JA; Bertozzi CR
    Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9116-21. PubMed ID: 12874386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Deoxy-4-fluoro-GalNAz (4FGalNAz) Is a Metabolic Chemical Reporter of O-GlcNAc Modifications, Highlighting the Notable Substrate Flexibility of O-GlcNAc Transferase.
    Jackson EG; Cutolo G; Yang B; Yarravarapu N; Burns MWN; Bineva-Todd G; Roustan C; Thoden JB; Lin-Jones HM; van Kuppevelt TH; Holden HM; Schumann B; Kohler JJ; Woo CM; Pratt MR
    ACS Chem Biol; 2022 Jan; 17(1):159-170. PubMed ID: 34931806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAcylation of the human epidermal growth factor receptor.
    Stateva SR; Villalobo A
    Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct One-Step Fluorescent Labeling of O-GlcNAc-Modified Proteins in Live Cells Using Metabolic Intermediates.
    Tan HY; Eskandari R; Shen D; Zhu Y; Liu TW; Willems LI; Alteen MG; Madden Z; Vocadlo DJ
    J Am Chem Soc; 2018 Nov; 140(45):15300-15308. PubMed ID: 30296064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical Reporters and Their Bioorthogonal Reactions for Labeling Protein
    Kim EJ
    Molecules; 2018 Sep; 23(10):. PubMed ID: 30241321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic precision labeling enables selective probing of O-linked
    Debets MF; Tastan OY; Wisnovsky SP; Malaker SA; Angelis N; Moeckl LKR; Choi J; Flynn H; Wagner LJS; Bineva-Todd G; Antonopoulos A; Cioce A; Browne WM; Li Z; Briggs DC; Douglas HL; Hess GT; Agbay AJ; Roustan C; Kjaer S; Haslam SM; Snijders AP; Bassik MC; Moerner WE; Li VSW; Bertozzi CR; Schumann B
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25293-25301. PubMed ID: 32989128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying potentially O-GlcNAcylated proteins using metabolic labeling, bioorthogonal enrichment, and Western blotting.
    Darabedian N; Pratt MR
    Methods Enzymol; 2019; 622():293-307. PubMed ID: 31155058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in metabolic chemical reporter structure yield a selective probe of O-GlcNAc modification.
    Chuh KN; Zaro BW; Piller F; Piller V; Pratt MR
    J Am Chem Soc; 2014 Sep; 136(35):12283-95. PubMed ID: 25153642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners.
    Yu SH; Boyce M; Wands AM; Bond MR; Bertozzi CR; Kohler JJ
    Proc Natl Acad Sci U S A; 2012 Mar; 109(13):4834-9. PubMed ID: 22411826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of structural and functional O-linked N-acetylglucosamine-bearing proteins in Xenopus laevis oocyte.
    Dehennaut V; Slomianny MC; Page A; Vercoutter-Edouart AS; Jessus C; Michalski JC; Vilain JP; Bodart JF; Lefebvre T
    Mol Cell Proteomics; 2008 Nov; 7(11):2229-45. PubMed ID: 18617508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global identification of O-GlcNAc-modified proteins.
    Nandi A; Sprung R; Barma DK; Zhao Y; Kim SC; Falck JR; Zhao Y
    Anal Chem; 2006 Jan; 78(2):452-8. PubMed ID: 16408927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.
    Hu J; Gao Q; Yang Y; Xia J; Zhang W; Chen Y; Zhou Z; Chang L; Hu Y; Zhou H; Liang L; Li X; Long Q; Wang K; Huang A; Tang N
    Theranostics; 2021; 11(2):805-823. PubMed ID: 33391506
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.